Gene · 977
Papers2,195
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,195
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Protective cardiovascular benefits of exercise training as measured by circulating endothelial cells and high-density lipoprotein in adults. | J Taibah Univ Med Sci | 2022 | 35983453 | PubTator, text mining | PubMed |
| Exosomes in osteoarthritis: Updated insights on pathogenesis, diagnosis, and treatment. | Front Cell Dev Biol | 2022 | 35959489 | PubTator, text mining | PubMed |
| Proteomic analysis of plasma exosomes in patients with non-small cell lung cancer. | Transl Lung Cancer Res | 2022 | 35958340 | PubTator, text mining | PubMed |
| Reappraising host cellular factors involved in attachment and entry to develop antiviral strategies against porcine reproductive and respiratory syndrome virus. | Front Microbiol | 2022 | 35958155 | PubTator, text mining | PubMed |
| A Comprehensive Prognostic Analysis of Tumor-Related Blood Group Antigens in Pan-Cancers Suggests That SEMA7A as a Novel Biomarker in Kidney Renal Clear Cell Carcinoma. | Int J Mol Sci | 2022 | 35955933 | PubTator, text mining | PubMed |
| Epidemiology and Molecular Biology of HPV Variants in Cervical Cancer: The State of the Art in Mexico. | Int J Mol Sci | 2022 | 35955700 | PubTator, text mining | PubMed |
| TM4SF5-Mediated Regulation of Hepatocyte Transporters during Metabolic Liver Diseases. | Int J Mol Sci | 2022 | 35955521 | PubTator, text mining | PubMed |
| Stem Cells as Target for Prostate cancer Therapy: Opportunities and Challenges. | Stem Cell Rev Rep | 2022 | 35951166 | PubTator, text mining | PubMed |
| mTORC1 controls Golgi architecture and vesicle secretion by phosphorylation of SCYL1. | Nat Commun | 2022 | 35948564 | PubTator, text mining | PubMed |
| Noncoding RNA-mediated molecular bases of chemotherapy resistance in hepatocellular carcinoma. | Cancer Cell Int | 2022 | 35945536 | PubTator, text mining | PubMed |
| CD44 Glycosylation as a Therapeutic Target in Oncology. | Front Oncol | 2022 | 35936713 | PubTator, text mining | PubMed |
| Serum N-glycomic profiling may provide potential signatures for surveillance of COVID-19. | Glycobiology | 2022 | 35925863 | PubTator, text mining | PubMed |
| FASN inhibitor TVB-3166 prevents S-acylation of the spike protein of human coronaviruses. | J Lipid Res | 2022 | 35921881 | PubTator, text mining | PubMed |
| Characterization of protein complexes in extracellular vesicles by intact extracellular vesicle crosslinking mass spectrometry (iEVXL). | J Extracell Vesicles | 2022 | 35918900 | PubTator, text mining | PubMed |
| The Exosome Journey: From Biogenesis to Regulation and Function in Cancers. | J Oncol | 2022 | 35898929 | PubTator, text mining | PubMed |
| A comprehensive analysis of ncRNA-mediated interactions reveals potential prognostic biomarkers in prostate adenocarcinoma. | Comput Struct Biotechnol J | 2022 | 35891787 | PubTator, text mining | PubMed |
| Inducible miR-150 Inhibits Porcine Reproductive and Respiratory Syndrome Virus Replication by Targeting Viral Genome and Suppressor of Cytokine Signaling 1. | Viruses | 2022 | 35891465 | PubTator, text mining | PubMed |
| Characterization and Genomic Analysis of a New Phage Infecting Helicobacter pylori. | Int J Mol Sci | 2022 | 35887231 | PubTator, text mining | PubMed |
| Role of Signaling Pathways in the Viral Life Cycle 2.0. | Int J Mol Sci | 2022 | 35887205 | PubTator, text mining | PubMed |
| Circulating Exosome Cargoes Contain Functionally Diverse Cancer Biomarkers: From Biogenesis and Function to Purification and Potential Translational Utility. | Cancers (Basel) | 2022 | 35884411 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/977/papers?page=20